Literature DB >> 8908166

Epithelioid sarcoma with an 18q aberration.

H Iwasaki1, Y Ohjimi, M Ishiguro, T Isayama, Y Kaneko, S Yoh, G Emoto, M Kikuchi.   

Abstract

Epithelioid sarcoma is a peculiar soft-tissue neoplasm of uncertain origin, which is characterized by an epithelioid morphology of tumor cells coexpressing epithelial (keratin) and nonepithelial (vimentin) antigens. We herein report a new cytogenetic abnormality with der(22)t(18;22)(q11;p11.2) in a case of epithelioid sarcoma that occurred in the elbow of a 75-year-old man. Histologically, the tumor demonstrated a multinodular proliferation of epithelioid cells, with positive immunostaining for keratin, epithelial membrane antigen (EMA), and vimentin. Cultured tumor cells obtained from fresh surgical materials were frozen in plastic ampules and stocked in a liquid nitrogen freezer. Six years after surgery, the cells were recovered from the freezer and utilized for both morphologic and cytogenetic analyses. These cultured cells both before and after the freezing exhibited essentially the same epithelioid morphology and immunophenotypes as those of the original tumor. A chromosome analysis, together with fluorescence in situ hybridization (FISH), demonstrated a 61-67 modal population, and a characteristic clonal abnormality with der(22)t(18;22)(q11;p11.2). Other clonal abnormalities included numerical (-3, -4, +7, -13, -14, -16, -18, +20, -22) and structural (8p+, 9p+, 12p+, i(21q)) aberrations. Some variant clones also demonstrated i(18q). Since the breakpoint at 18q11 is similar to that reported in synovial sarcoma, this finding may support the presence of a histogenetic relationship between epithelioid sarcoma and synovial sarcoma. Our study thus indicates that the storage of frozen cells is useful for both morphologic and cytogenetic analyses of soft tissue tumors.

Entities:  

Mesh:

Year:  1996        PMID: 8908166     DOI: 10.1016/s0165-4608(95)00315-0

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

Review 1.  Epithelioid Sarcoma: Opportunities for Biology-Driven Targeted Therapy.

Authors:  Jonathan Noujaim; Khin Thway; Zia Bajwa; Ayeza Bajwa; Robert G Maki; Robin L Jones; Charles Keller
Journal:  Front Oncol       Date:  2015-08-17       Impact factor: 6.244

Review 2.  Beyond SMARCB1 Loss: Recent Insights into the Pathobiology of Epithelioid Sarcoma.

Authors:  Elisa Del Savio; Roberta Maestro
Journal:  Cells       Date:  2022-08-24       Impact factor: 7.666

3.  A novel angiomatoid epithelioid sarcoma cell line, Asra-EPS, forming tumors with large cysts containing hemorrhagic fluid in vivo.

Authors:  Yoshinori Imura; Norifumi Naka; Hidetatsu Outani; Hirohiko Yasui; Satoshi Takenaka; Ken-ichiro Hamada; Ritsuro Ozaki; Mitsunori Kaya; Ken-ichi Yoshida; Eiichi Morii; Akira Myoui; Hideki Yoshikawa
Journal:  BMC Res Notes       Date:  2013-08-01

4.  High expression of CD109 antigen regulates the phenotype of cancer stem-like cells/cancer-initiating cells in the novel epithelioid sarcoma cell line ESX and is related to poor prognosis of soft tissue sarcoma.

Authors:  Makoto Emori; Tomohide Tsukahara; Masaki Murase; Masanobu Kano; Kenji Murata; Akari Takahashi; Terufumi Kubo; Hiroko Asanuma; Kazuyo Yasuda; Vitaly Kochin; Mitsunori Kaya; Satoshi Nagoya; Jun Nishio; Hiroshi Iwasaki; Tomoko Sonoda; Tadashi Hasegawa; Toshihiko Torigoe; Takuro Wada; Toshihiko Yamashita; Noriyuki Sato
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.